Ayala Pharmaceuticals Inc (ADXS)

[cab033]

I think the biggest piece of your statement is no CMO by April. There will be no new CEO until $ issues are resolved. If the cash balances are still low by April with no near term resolution for cash needs, then the interim will issue shares and then be replaced. If a CMO is brought in before then, this is even more of a possibility. If, if, if, the company is not looking to sell now and wants to hold off a year or 2 for more money, then someone will have to do the dirty work of rasing cash and who better than a interim CEO on the way out the door for retirement. Then cash reserves are solid, a new CEO can be brought in, and then as new data rolls in the SP should climb accordingly for an eventual BO at much higher prices than 20. But I agree, if neither are brought on within 6 months, something is going.